UBS ASSET MANAGEMENT AMERICAS LLC - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$40,025,000
-29.4%
990,262
+0.5%
0.04%
-18.5%
Q2 2015$56,723,000
-2.5%
985,631
+7.8%
0.05%
-3.6%
Q1 2015$58,193,000
+25.5%
913,980
+21.7%
0.06%
+27.3%
Q4 2014$46,360,000
+50.8%
750,897
-5.2%
0.04%
+46.7%
Q3 2014$30,742,000
+17.7%
791,697
+4.4%
0.03%
+15.4%
Q2 2014$26,113,000
+44.6%
757,997
+81.3%
0.03%
+36.8%
Q1 2014$18,062,000
+26.9%
417,997
+17.0%
0.02%
+18.8%
Q4 2013$14,231,000
+64.6%
357,197
+55.1%
0.02%
+45.5%
Q3 2013$8,648,000
+550.2%
230,357
+365.4%
0.01%
+450.0%
Q2 2013$1,330,00049,4970.00%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC in Q2 2015.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC shareholders